drugset / Trial / NCT00754884

Calcitonin in the Treatment of Fibromyalgia

NCT00754884

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine whether nasal administration of salmon calcitonin is effective and safe in the treatment of symptoms and signs of primary fibromyalgia.

Timeline

Start
2008-10
Primary completion
2009-02
Completion
2009-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject salmon calcitonin Unknown 200 iu Intranasal

Indications